glp 1 agonist nash Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive The Rise of the GLP-1s:
Description
Gewitz, A

doi: 10.2337/dc16-2725

Hori M, Hasegawa Y, Hayashi Y, Nakagami T, Harada-Shiba M

Hirano T, Mori Y

Pharmaceutical companies are working on innovative formulations, improved bioavailability, combination treatments, and modes of administration
Finan B, Yang B, Ottaway N, Smiley DL, Ma T, Clemmensen C, et al
